New Advances in Cancer-related Fatigue Assessment Tools

doi:10.12114/j.issn.1007-9572.2022.0060

Chinese General Practice ›› 2022, Vol. 25 ›› Issue (21): 2686-2690.DOI: 10.12114/j.issn.1007-9572.2022.0060

Special Issue: 肿瘤最新文章合集

• Expanding Outlook·Research Methods • Previous Articles

New Advances in Cancer-related Fatigue Assessment Tools

1. The First Clinical Medical College, Beijing University of Chinese Medicine, Beijing 100020, China
2. Department of Hematology & Oncology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100010, China
3. Beijing Dongcheng District Community Health Service Management Center, Beijing 100010, China

Received:2022-01-19 Revised:2022-03-15 Published:2022-07-20 Online:2022-05-19
Contact: Shaodan TIAN
About author:
MIAO L, TIAN S D, LI J K, et al. New advances in cancer-related fatigue assessment tools[J]. Chinese General Practice, 2022, 25 (21) : 2686-2690.

癌症相关性疲乏评估量表研究进展与应用

1．100020　北京市，北京中医药大学第一临床医学院
2．100010　北京市，北京中医药大学东直门医院血液肿瘤科
3．100010　北京市，北京市东城区社区卫生服务管理中心

通讯作者: 田劭丹
作者简介:
苗璐，田劭丹，李加葵，等.癌症相关性疲乏评估量表研究进展与应用[J].中国全科医学，2022，25（21）：2686-2690. [www.chinagp.net] 作者贡献：苗璐负责论文起草、编写，检索追溯文献及文献思路整理；田劭丹提出论文命题及国内中医药研究建立中医量表的迫切需求，指导该论文撰写并负责论文最终版本修订检查，对论文整体负责；李加葵负责检索数据提取统计数据；王婧负责查找最新文献，提出论文编写框架结构；陈信义作为课题负责人，负责课题研究思路、方案设计及该论文撰写指导。
基金资助:
北京市科委科技计划重大项目(D131100002213002)

Abstract

Abstract:

Cancer-related fatigue (CRF) is a common symptom that occurs in most cancer patients and survivors. Traditional Chinese Medicine (TCM) has proven to have unique values in clinical treatment of CRF in China, although still needs to be supported by higher level of clinical evidence as modern medicine develops. How to select an appropriate tool to assess CRF is essential to objectively estimate the treatment effect in clinical research on CRF using TCM. We reviewed the common tools used for assessing CRF in clinical research, and discussed the necessity of promoting the development of a standard TCM syndrome scale for CRF, so as to promote the standardization process of TCM treatment of CRF.

Key words: Neoplasms, Fatigue, Cancer related fatigue, Assessment scale, Review

摘要：

癌症相关性疲乏（CRF）是一种困扰着大多数癌症患者及癌症幸存者的常见症状。中医药在我国临床治疗CRF中具有独特优势，但在现代医学发展模式下，仍需要进一步开展临床研究以提供更高质量的证据。中医药临床研究过程中如何选择合适的疲乏评估工具对客观评价治疗效果十分关键。现针对CRF临床研究中常用的量表进行探讨，并提出推进建立CRF中医证候标准量表的必要性，以更好推动中医药治疗CRF的标准化进程。

关键词: 肿瘤, 疲劳, 癌症相关性疲乏, 评估量表, 综述

Lu MIAO,Shaodan TIAN,Jiakui LI, et al. New Advances in Cancer-related Fatigue Assessment Tools[J]. Chinese General Practice, 2022, 25(21): 2686-2690. DOI: 10.12114/j.issn.1007-9572.2022.0060.
苗璐,田劭丹,李加葵等. 癌症相关性疲乏评估量表研究进展与应用[J]. 中国全科医学, 2022, 25(21): 2686-2690. DOI: 10.12114/j.issn.1007-9572.2022.0060.

References 35

[1]	中华医学会肿瘤学分会肿瘤支持康复治疗学组.中国癌症相关性疲乏临床实践诊疗指南（2021年版）[J].中国癌症杂志，2021，31（9）：852-872. DOI：10.19401/j.cnki.1007-3639.2021.09.012.
[2]	HENRY D H, VISWANATHAN H N, ELKIN E P，et al. Symptoms and treatment burden associated with cancer treatment：results from a cross-sectional national survey in the US[J]. Support Care Cancer，2008，16（7）：791-801. DOI：10.1007/s00520-007-0380-2.
[3]	WANG X S, ZHAO F M, FISCH M J，et al. Prevalence and characteristics of moderate to severe fatigue：a multicenter study in cancer patients and survivors[J]. Cancer，2014，120（3）：425-432. DOI：10.1002/cncr.28434.
[4]	周婷，张晶，于建春，等. 癌因性疲乏流行病学调查浅析[J]. 临床医药文献电子杂志，2018，5（30）：172. DOI：10.3877/j.issn.2095-8242.2018.30.140.
[5]	MENDOZA T R, WANG X S, CLEELAND C S，et al. The rapid assessment of fatigue severity in cancer patients：use of the Brief Fatigue Inventory[J]. Cancer，1999，85（5）：1186-1196.
[6]	WANG X S, HAO X S, WANG Y，et al. Validation study of the Chinese version of the Brief Fatigue Inventory （BFI-C）[J]. J Pain Symptom Manage，2004，27（4）：322-332.
[7]	LEE K A, HICKS G, NINO-MURCIA G. Validity and reliability of a scale to assess fatigue[J]. Psychiatry Res，1991，36（3）：291-298. DOI：10.1016/0165-1781(91)90027-m.
[8]	KNOBEL H, LOGE J H, BRENNE E，et al. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors[J]. Palliat Med，2003，17（8）：664-672.
[9]	WEIS J, TOMASZEWSKI K A, HAMMERLID E，et al. International psychometric validation of an EORTC quality of life module measuring cancer related fatigue （EORTC QLQ-FA12）[J]. J Natl Cancer Inst，2017，109（5）. DOI：10.1093/jnci/djw273.
[10]	STOREY D J, WATERS R A, HIBBERD C J，et al. Clinically relevant fatigue in cancer outpatients：the Edinburgh Cancer Centre symptom study[J]. Ann Oncol，2007，18（11）：1861-1869.
[11]	PIPER B F. Piper fatigue scale available for clinical testing[J]. Oncol Nurs Forum，1990，17（5）：661-662.
[12]	PIPER B F, DIBBLE S L, DODD M J，et al. The revised Piper Fatigue Scale：psychometric evaluation in women with breast cancer[J]. Oncol Nurs Forum，1998，25（4）：677-684.
[13]	REEVE B B, STOVER A M, ALFANO C M，et al. The Piper Fatigue Scale-12 （PFS-12）：psychometric findings and item reduction in a cohort of breast cancer survivors[J]. Breast Cancer Res Treat，2012，136（1）：9-20. DOI：10.1007/s10549-012-2212-4.
[14]	STEIN K D, MARTIN S C, HANN D M，et al. A multidimensional measure of fatigue for use with cancer patients[J]. Cancer Pract，1998，6（3）：143-152. DOI：10.1046/j.1523-5394.1998.006003143.x.
[15]	DONOVAN K A, STEIN K D, LEE M，et al. Systematic review of the multidimensional fatigue symptom inventory-short form[J]. Support Care Cancer，2015，23（1）：191-212. DOI：10.1007/s00520-014-2389-7.
[16]	PIEN L C, CHU H, CHEN W C，et al. Reliability and validity of a Chinese version of the Multidimensional Fatigue Symptom Inventory-Short Form （MFSI-SF-C）[J]. J Clin Nurs，2011，20（15/16）：2224-2232. DOI：10.1111/j.1365-2702.2010.03691.x.
[17]	HANN D M, JACOBSEN P B, AZZARELLO L M，et al. Measurement of fatigue in cancer patients：development and validation of the Fatigue Symptom Inventory[J]. Qual Life Res，1998，7（4）：301-310. DOI：10.1023/a:1024929829627.
[18]	HANN D M, DENNISTON M M, BAKER F. Measurement of fatigue in cancer patients：further validation of the Fatigue Symptom Inventory[J]. Qual Life Res Int J Qual Life Aspects Treat Care Rehabilitation，2000，9（7）：847-854.
[19]	SHUN S C, BECK S L, PETT M A，et al. Psychometric testing of three Chinese fatigue instruments in Taiwan[J]. J Pain Symptom Manage，2006，32（2）：155-167. DOI：10.1016/j.jpainsymman.2006.02.011.
[20]	SMETS E M, GARSSEN B, BONKE B，et al. The Multidimensional Fatigue Inventory （MFI） psychometric qualities of an instrument to assess fatigue[J]. J Psychosom Res，1995，39 （3）：315-325. DOI：10.1016/0022-3999(94)00125-o.
[21]	HEDLUND L, GYLLENSTEN A L, HANSSON L. A psychometric study of the multidimensional fatigue inventory to assess fatigue in patients with schizophrenia spectrum disorders[J]. Community Ment Health J，2015，51（3）：377-382. DOI：10.1007/s10597-014-97460-3.
[22]	MUNCH T N, STROMGREN A S, PEDERSEN L，et al. Multidimensional measurement of fatigue in advanced cancer patients in palliative care: an application of the multidimensional fatigue inventory[J]. J Pain Symptom Manage，2006，31（6）：533-541. DOI:10.1016/j.jpainsymman.2005.11.012.
[23]	SCHWARTZ A L. The Schwartz Cancer Fatigue Scale：testing reliability and validity[J]. Oncol Nurs Forum，1998，25（4）：711-717.
[24]	SCHWARTZ A, MEEK P. Additional construct validity of the Schwartz Cancer Fatigue Scale[J]. J Nurs Meas，1999，7（1）：35-45.
[25]	SHUN S C, BECK S L, PETT M A，et al. Psychometric testing of three Chinese fatigue instruments in Taiwan[J]. J Pain Symptom Manage，2006，32（2）：155-167. DOI：10.1016/j.jpainsymman.2006.02.011.
[26]	OKUYAMA T, AKECHI T, KUGAYA A，et al. Development and validation of the cancer fatigue scale：a brief，three-dimensional，self-rating scale for assessment of fatigue in cancer patients[J]. J Pain Symptom Manage，2000，19（1）：5-14. DOI：10.1016/s0885-3924(99)00138-4.
[27]	张凤玲，丁玥，韩丽沙. 癌症疲乏量表中文版的信效度[J]. 中国心理卫生杂志，2011，25（11）：810-813. DOI：10.3969/j.issn.1000-6729.2011.11.003.
[28]	YELLEN S B, CELLA D F, WEBSTER K，et al. Measuring fatigue and other Anemia-related symptoms with the Functional Assessment of Cancer Therapy（FACT） measurement system[J]. J Pain Symptom Manage，1997，13（2）：63-74. DOI：10.1016/s0885-3924(96)00274-6.
[29]	CELLA D F, TULSKY D S, GRAY G，et al. The Functional Assessment of Cancer Therapy scale：development and validation of the general measure[J]. J Clin Oncol，1993，11（3）：570-579. DOI：10.1200/JCO.1993.11.3.570.
[30]	高昶，张翠翠，徐佟，等. 中文版癌症治疗功能评估疲乏量表在肿瘤患者中应用的信效度分析[J]. 中国全科医学，2016，19（21）：2596-2600. DOI：10.3969/j.issn.1007-9572.2016.21.021.
[31]	屈玲玲，朱丽，黄玲玲，等. 心理-运动-睡眠三联康复干预对肺癌化疗患者心理状态、睡眠质量及癌因性疲乏的改善作用[J]. 中国现代医生，2020，58（5）：87-90.
[32]	DU X T, TIAN W P, LIU B，et al. A randomized controlled study of acupuncture in the prevention and treatment of carcinogenic fatigue caused by chemotherapy for colorectal cancer[J].World Journal of Acupuncture-Moxibustion，2021，31（2）：83-88.
[33]	王健康，侯炜.中成药治疗癌因性疲乏的临床研究现状[J].中医药导报，2019，25（16）：52-54，65. DOI：10.13862/j.cnki.cn43-1446/r.2019.16.013.
[34]	张振，田雪飞，邓哲，等.基于"证候-证素-病症"探讨建立癌因性疲乏中医证候量表的方法[J].中医药信息，2020，37（2）：36-39. DOI：10.19656/j.cnki.1002-2406.200039.
[35]	戴霞，郭伟星. 中医证候量表条目量化的方法学初探[J]. 辽宁中医杂志，2010，37（8）：1477-1478. DOI：10.13192/j.ljtcm.2010.08.74.daix.064.

New Advances in Cancer-related Fatigue Assessment Tools

癌症相关性疲乏评估量表研究进展与应用

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References 35

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180.
[2]	WANG Xu, WEI Xu, ZHU Liguo, FENG Tianxiao, WANG Zhipeng, SHI Bin. Research Ideas of the Efficacy Mechanism and Prospect Analysis of Traditional Chinese Manipulative Therapy on Treating Spinal Degenerative Diseases with Combination of Medicine and Industry [J]. Chinese General Practice, 2023, 26(33): 4118-4124.
[3]	XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109.
[4]	ZHANG Siyu, ZHOU Yuqiu, DU Xiaohui, WANG Zhengjun. Advances in Duration of Untreated Psychosis and Its Early Intervention [J]. Chinese General Practice, 2023, 26(33): 4110-4117.
[5]	LI Yujing, JIN Yichao, CHEN Xing, JI Mengying, DAI Huihua. Risk Factors for Endometrial Lesions Detected by Hysteroscopy in Breast Cancer Patients Taking Tamoxifen [J]. Chinese General Practice, 2023, 26(32): 4026-4030.
[6]	MENG Jiangtao, YANG Siyu, SUN Lei, LEI Ruining, ZHAO Xiaoxia. Advances in the Prognostic Value of Diffusion Tensor Imaging with Motor Evoked Potential for Motor Function in Cerebral Infarction Patients with Hemiplegia [J]. Chinese General Practice, 2023, 26(32): 4098-4102.
[7]	ZHANG Jifang, CHEN Fang, TANG Jiawen, LI Hongliang. Predictive Value of Tumor Budding and Tumor-infiltrating Lymphocytes on Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma [J]. Chinese General Practice, 2023, 26(32): 4038-4042.
[8]	GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037.
[9]	WANG Jiaxin, ZHAO Yali. Domestic and International Assessment Tools for Medical Teamwork: a Systematic Review [J]. Chinese General Practice, 2023, 26(31): 3951-3962.
[10]	WEI Mengyu, WANG Jiajia, ZHANG Yingying, LI Chunyang, LI Jiansheng. Research Status of Patient-reported Outcome Assessment Tools for Obstructive Sleep Apnea [J]. Chinese General Practice, 2023, 26(30): 3725-3733.
[11]	ZHANG Ming, XU Jing, SUN Zhenhua, ZHAO Wenhao, MA Yingqian, ZHANG Jianqiao, SHEN Haiping. Improvement of Nutritional Status of Elderly Patients with Severe Obstruction Esophageal Carcinoma by Image-guided Photodynamic Therapy [J]. Chinese General Practice, 2023, 26(30): 3780-3784.
[12]	XIAO Yuqian, BAI Yanjie, WANG Yan, CHEN Shuying, CHEN Limin, SUN Kexin, WAN Jun. Research Progress of Mitochondrial Transfer in Post-stroke Cognitive Impairment [J]. Chinese General Practice, 2023, 26(30): 3833-3840.
[13]	LI Jilei, LI Honglin, XU Yanchao, LIU Yanan, CHEN Mengli, SHAO Shuai, MA Chunzheng. Clinical Study on the Combination of Xiaotan Huayu Tongyi Granules, Channel Kaijie Pills and Chemotherapy in the Treatment of Esophageal Cancer [J]. Chinese General Practice, 2023, 26(30): 3759-3764.
[14]	ZHENG Yuling, ZHANG Yaling, LIU Huaimin, XU Yanchao, JIA Xiaolin, LI Junsai, HE Wenlong, TONG Xinduo, QIN Shanwen, ZHANG Lihan. Clinical Observation of Dingxiang Guanshitong Hanhua Pills Alone and Its Combination with Fugui Guanshitong Granules in the Treatment of Advanced Esophageal Cancer [J]. Chinese General Practice, 2023, 26(30): 3765-3771.
[15]	YUAN Xiwei, NAN Yuemin. Research Progress of Structure, Function and Mechanism of Action of Mitofusin 2 in Liver Diseases [J]. Chinese General Practice, 2023, 26(30): 3841-3846.